Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on: June 18,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on:June 18,2026

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000

Updated on: June 20,2026

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000

Updated on:June 20,2026

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

Updated on: June 20,2026

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

Updated on:June 20,2026

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Updated on: June 20,2026

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Updated on:June 20,2026

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Updated on: June 19,2026

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Updated on:June 19,2026

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr

Updated on: June 19,2026

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr

Updated on:June 19,2026